In an adult male on sertraline, could the drug be causing hypogonadism, and how should low testosterone be evaluated and managed?

Sertraline Can Cause Hypogonadism: Evaluate and Manage Systematically

Yes, sertraline can directly cause hypogonadism through suppression of testicular steroid production and disruption of the hypothalamic-pituitary-gonadal axis, requiring systematic evaluation to distinguish drug-induced from organic causes before considering testosterone replacement.

Mechanism of Sertraline-Induced Hypogonadism

Sertraline causes compensatory hypogonadism through multiple mechanisms 1, 2:

• Direct testicular suppression: Reduces testosterone production via downregulation of steroidogenic pathways, particularly the testicular Δ-4 axis
• Increased LH levels: The pituitary attempts to compensate for low testosterone by increasing luteinizing hormone, creating a state of "compensatory hypogonadism" where the HPG axis is working harder but producing less testosterone 2
• Sexual dysfunction: FDA labeling confirms ejaculatory failure occurs in 14% of men on sertraline (vs 1% placebo), and decreased libido in 6% (vs 1% placebo) 1

Animal studies demonstrate sertraline significantly reduces testosterone levels and testicular Johnsen scores, with effects most pronounced at therapeutic doses 2, 3.

Evaluation Algorithm

Step 1: Confirm Hypogonadism

Check morning total testosterone levels twice (before 10 AM) to confirm persistent low testosterone 4. The 2025 EAU guidelines emphasize avoiding testing during acute illness 4.

Step 2: Identify Drug as Causative Agent

The 2025 EAU guidelines explicitly state: "Check for drugs and substances that can interfere with T production/action" and "Investigate if drugs or substances that may interfere with hypothalamic-pituitary axis can be eliminated" 4.

Key distinguishing features of sertraline-induced hypogonadism:

• Elevated or inappropriately normal LH (compensatory response) 2
• Temporal relationship: symptoms began after sertraline initiation
• No other organic causes identified

Step 3: Rule Out Organic Causes

Evaluate for 4:

• Pituitary disorders: Check FSH, LH, prolactin
• Metabolic comorbidities: Obesity, metabolic syndrome, type 2 diabetes (these independently cause functional hypogonadism)
• Other medications: Opioids, glucocorticoids
• Primary testicular failure: Check testicular exam, history of trauma/infection

Management Strategy

First-Line: Modify or Discontinue Sertraline

The 2025 EAU guidelines prioritize eliminating interfering drugs before considering testosterone therapy 4. This is critical because:

1. Sertraline-induced hypogonadism may be reversible if the drug is discontinued or switched
2. Starting testosterone while continuing sertraline treats the symptom but not the cause
3. Testosterone therapy will suppress fertility by shutting down the HPG axis 4

Action steps:

• Discuss with prescribing psychiatrist about switching to a non-SSRI antidepressant (e.g., bupropion, which may actually improve sexual function)
• If sertraline must continue, consider dose reduction
• Allow 2-3 months after discontinuation to reassess testosterone levels (sertraline half-life is 26 hours, but HPG axis recovery takes longer)

Second-Line: Address Metabolic Factors

The 2025 EAU guidelines emphasize that functional hypogonadism commonly correlates with obesity and metabolic disorders 4. Even if sertraline is contributory:

• Weight loss through low-calorie diet can reverse obesity-associated secondary hypogonadism
• Physical activity shows similar benefits
• These interventions increase testosterone by 1-2 nmol/L 4

Third-Line: Consider Testosterone Replacement (If Drug Cannot Be Stopped)

Only consider testosterone if sertraline cannot be discontinued AND symptoms persist after addressing metabolic factors 4, 5.

The 2020 ACP guidelines provide clear recommendations 5:

For sexual dysfunction specifically:

• Discuss potential benefits, harms, costs, and patient preferences before initiating 5
• Reevaluate at 12 months: Discontinue if no improvement in sexual function 5
• Use intramuscular over transdermal formulations (lower cost, similar efficacy) 5

Do NOT use testosterone for:

• Energy, vitality, physical function, or cognition (conditional recommendation against) 5

Critical Contraindication: Fertility Concerns

Testosterone therapy is absolutely contraindicated in men seeking fertility 4. If the patient desires fertility:

• Stop sertraline if possible
• For secondary hypogonadism with persistent low testosterone after sertraline discontinuation, use gonadotropin therapy (hCG + FSH) instead of testosterone 4

Common Pitfalls to Avoid

1. Starting testosterone without attempting sertraline discontinuation: This converts potentially reversible drug-induced hypogonadism into permanent testosterone dependence
2. Ignoring metabolic comorbidities: Obesity, diabetes, and metabolic syndrome independently cause functional hypogonadism and must be addressed 4
3. Not checking LH/FSH: Elevated LH with low testosterone suggests compensatory hypogonadism (drug-induced or functional), not organic primary/secondary hypogonadism
4. Testing during acute illness or stress: This yields falsely low testosterone levels 4
5. Using testosterone in men desiring fertility: This will worsen fertility by suppressing spermatogenesis 4

Monitoring If Testosterone Is Initiated

Per 2025 EAU guidelines 4:

• Reassess symptoms at 12 months and periodically thereafter
• Monitor for contraindications to testosterone therapy
• Check testosterone levels, hematocrit, and PSA (in men >40 years) at baseline and annually

The key principle: Treat the cause (sertraline), not just the consequence (low testosterone), whenever clinically feasible.